Nomura Holdings’s Generation Bio GBIO Stock Holding History

Nomura Holdings’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,353	Closed	-$308K	–	2125
2021 Q4	$308K	Buy	+4,353	New	+$760K	﹤0.01%	1672

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Nomura Holdings's GBIO Position: Q1 2022 in Review

Nomura Holdings sold out of Generation Bio (GBIO) in Q1 2022, closing a stake of 4,353 shares — an estimated $308K sold.

Nomura Holdings first reported a position in GBIO in Q4 2021 and held it in 1 quarter. The position peaked at $308K in Q4 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q1 2022.

Nomura Holdings reported no remaining Generation Bio position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 4,353 Generation Bio shares in Q1 2022, an estimated $308K.
Nomura Holdings first reported a position in Generation Bio in Q4 2021 and held it in 1 quarter.
Nomura Holdings's Generation Bio position peaked at $308K in Q4 2021.
88 funds tracked by Wall St. Rank held Generation Bio as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.